AnaptysBio, Inc. is an American biopharmaceutical company engaged in the development of therapeutic antibody product candidates. It is focused on unmet medical needs in inflammation and it is known for its antibody generation technology in the biopharmaceutical industry.
Operational in the biotechnology sector, AnaptysBio is distinguished for its use of a proprietary somatic hypermutation (SHM) platform to generate antibody therapeutics. It also has multiple collaborations with other biopharma companies, including GlaxoSmithKline.
Diversify your virtual portfolio by following ANAB shares on eToro.